ClinicalTrials.gov record
A Study to Determine the Safety and Efficacy of Albiglutide Administered in Combination With Insulin Glargine
ClinicalTrials.gov ID: NCT00976391
Public ClinicalTrials.gov record NCT00976391. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter Study to Determine the Safety and Efficacy of Albiglutide Administered in Combination With Insulin Glargine as Compared With the Combination of Insulin Glargine and Preprandial Lispro Insulin in Subjects With Type 2 Diabetes Mellitus
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study will examine the safety and efficacy of albiglutide in combination with insulin glargine as compared with the combination of insulin glargine and preprandial lispro insulin in subjects with type 2 diabetes.
Study identification
- NCT ID
- NCT00976391
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 586 participants
Conditions and interventions
Conditions
Interventions
Biological · Drug
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 2009 (Type not available)
- Primary completion
- Oct 2011 (Actual)
- Completion
- May 2012 (Actual)
- Last update posted
- Jan 11, 2017
2009 – 2012
United States locations
- U.S. sites
- 142
- U.S. states
- 37
- U.S. cities
- 122
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| GSK Investigational Site | Birmingham | Alabama | 35205 | — |
| GSK Investigational Site | Dothan | Alabama | 36301 | — |
| GSK Investigational Site | Gilbert | Arizona | 85295 | — |
| GSK Investigational Site | Phoenix | Arizona | 85028 | — |
| GSK Investigational Site | Phoenix | Arizona | 85050 | — |
| GSK Investigational Site | Jonesboro | Arkansas | 72401 | — |
| GSK Investigational Site | Searcy | Arkansas | 72143 | — |
| GSK Investigational Site | Chino | California | 91710 | — |
| GSK Investigational Site | Commerce | California | 90040 | — |
| GSK Investigational Site | Fresno | California | 93720 | — |
| GSK Investigational Site | Fullerton | California | 92835 | — |
| GSK Investigational Site | Huntington Beach | California | 92646 | — |
| GSK Investigational Site | La Jolla | California | 92037 | — |
| GSK Investigational Site | Long Beach | California | 90806 | — |
| GSK Investigational Site | Los Alamitos | California | 90720 | — |
| GSK Investigational Site | Los Angeles | California | 90073 | — |
| GSK Investigational Site | Mission Viejo | California | 92691 | — |
| GSK Investigational Site | Sacramento | California | 95821 | — |
| GSK Investigational Site | San Diego | California | 92117 | — |
| GSK Investigational Site | San Diego | California | 92128 | — |
| GSK Investigational Site | San Diego | California | 92161 | — |
| GSK Investigational Site | Satna Monica | California | 90404 | — |
| GSK Investigational Site | Spring Valley | California | 91978 | — |
| GSK Investigational Site | Tustin | California | 92780 | — |
| GSK Investigational Site | Walnut Creek | California | 94598 | — |
| GSK Investigational Site | West Hills | California | 91307 | — |
| GSK Investigational Site | Denver | Colorado | 80220 | — |
| GSK Investigational Site | New Britain | Connecticut | 06050 | — |
| GSK Investigational Site | Trumbull | Connecticut | 06611 | — |
| GSK Investigational Site | Waterbury | Connecticut | 06708 | — |
| GSK Investigational Site | Boynton Beach | Florida | 33437 | — |
| GSK Investigational Site | Clearwater | Florida | 33756 | — |
| GSK Investigational Site | Cutler Bay | Florida | 33189 | — |
| GSK Investigational Site | Hallandale | Florida | 33009 | — |
| GSK Investigational Site | Jacksonville | Florida | 32205 | — |
| GSK Investigational Site | Lauderdale Lakes | Florida | 33319 | — |
| GSK Investigational Site | Miami | Florida | 33156 | — |
| GSK Investigational Site | Orlando | Florida | 32822 | — |
| GSK Investigational Site | Plantation | Florida | 33317 | — |
| GSK Investigational Site | West Palm Beach | Florida | 33401 | — |
| GSK Investigational Site | Atlanta | Georgia | 30308 | — |
| GSK Investigational Site | Atlanta | Georgia | 30338 | — |
| GSK Investigational Site | Blue Ridge | Georgia | 30513 | — |
| GSK Investigational Site | Columbus | Georgia | 31904 | — |
| GSK Investigational Site | Savannah | Georgia | 31419 | — |
| GSK Investigational Site | Snellville | Georgia | 30078 | — |
| GSK Investigational Site | Honolulu | Hawaii | 96813 | — |
| GSK Investigational Site | Honolulu | Hawaii | 96814 | — |
| GSK Investigational Site | Idaho Falls | Idaho | 83404 | — |
| GSK Investigational Site | La Grange | Illinois | 60525 | — |
| GSK Investigational Site | Avon | Indiana | 46123 | — |
| GSK Investigational Site | Evansville | Indiana | 47714 | — |
| GSK Investigational Site | Lafayette | Indiana | 47904 | — |
| GSK Investigational Site | Council Bluffs | Iowa | 51501 | — |
| GSK Investigational Site | Des Moines | Iowa | 50314 | — |
| GSK Investigational Site | Iowa City | Iowa | 52243 | — |
| GSK Investigational Site | Newton | Kansas | 67114 | — |
| GSK Investigational Site | Topeka | Kansas | 66606 | — |
| GSK Investigational Site | Lexington | Kentucky | 40503 | — |
| GSK Investigational Site | Lexington | Kentucky | 40504 | — |
| GSK Investigational Site | Shreveport | Louisiana | 71101 | — |
| GSK Investigational Site | Hyattsville | Maryland | 20782 | — |
| GSK Investigational Site | Haverhill | Massachusetts | 01830 | — |
| GSK Investigational Site | Ann Arbor | Michigan | 48106 | — |
| GSK Investigational Site | Benzonia | Michigan | 49616 | — |
| GSK Investigational Site | Bloomfield Hills | Michigan | 48302 | — |
| GSK Investigational Site | Dearborn | Michigan | 48124 | — |
| GSK Investigational Site | Kalamazoo | Michigan | 49009 | — |
| GSK Investigational Site | Kalamazoo | Michigan | 49048 | — |
| GSK Investigational Site | Picayune | Mississippi | 39466 | — |
| GSK Investigational Site | Chesterfield | Missouri | 63017 | — |
| GSK Investigational Site | Jefferson City | Missouri | 65109 | — |
| GSK Investigational Site | Kansas City | Missouri | — | — |
| GSK Investigational Site | Springfield | Missouri | 65807 | — |
| GSK Investigational Site | St Louis | Missouri | 63110 | — |
| GSK Investigational Site | St Louis | Missouri | 63141 | — |
| GSK Investigational Site | Great Falls | Montana | 59405 | — |
| GSK Investigational Site | Omaha | Nebraska | 68124 | — |
| GSK Investigational Site | Omaha | Nebraska | 68131 | — |
| GSK Investigational Site | Haddon Heights | New Jersey | 08035 | — |
| GSK Investigational Site | New York | New York | 10025 | — |
| GSK Investigational Site | North Massapequa | New York | 11758 | — |
| GSK Investigational Site | Asheville | North Carolina | 28803 | — |
| GSK Investigational Site | Burlington | North Carolina | 27215 | — |
| GSK Investigational Site | Durham | North Carolina | 27710 | — |
| GSK Investigational Site | Hickory | North Carolina | 28601 | — |
| GSK Investigational Site | Morehead City | North Carolina | 28557 | — |
| GSK Investigational Site | Tabor City | North Carolina | 28463 | — |
| GSK Investigational Site | Akron | Ohio | 44320 | — |
| GSK Investigational Site | Canal Fulton | Ohio | 44614 | — |
| GSK Investigational Site | Cincinnati | Ohio | 45245 | — |
| GSK Investigational Site | Cleveland | Ohio | 44122 | — |
| GSK Investigational Site | Columbus | Ohio | 43213 | — |
| GSK Investigational Site | Dayton | Ohio | 45439 | — |
| GSK Investigational Site | Oklahoma City | Oklahoma | 73103 | — |
| GSK Investigational Site | Oklahoma City | Oklahoma | 73104 | — |
| GSK Investigational Site | Tulsa | Oklahoma | 74104 | — |
| GSK Investigational Site | Tulsa | Oklahoma | 74136 | — |
| GSK Investigational Site | Bensalem | Pennsylvania | 19020 | — |
| GSK Investigational Site | Carlisle | Pennsylvania | 17013 | — |
| GSK Investigational Site | Tipton | Pennsylvania | 16684 | — |
| GSK Investigational Site | Uniontown | Pennsylvania | 15401 | — |
| GSK Investigational Site | Greenville | South Carolina | 29601 | — |
| GSK Investigational Site | Greenville | South Carolina | 29615 | — |
| GSK Investigational Site | Murrells Inlet | South Carolina | 29576 | — |
| GSK Investigational Site | Clarksville | Tennessee | 37043 | — |
| GSK Investigational Site | Johnson City | Tennessee | 37604 | — |
| GSK Investigational Site | McKenzie | Tennessee | 38201 | — |
| GSK Investigational Site | Memphis | Tennessee | 38125 | — |
| GSK Investigational Site | Tullahoma | Tennessee | 37398 | — |
| GSK Investigational Site | Arlington | Texas | 76012 | — |
| GSK Investigational Site | Bedford | Texas | 76201 | — |
| GSK Investigational Site | Corpus Christi | Texas | 78404 | — |
| GSK Investigational Site | Dallas | Texas | 75224 | — |
| GSK Investigational Site | Dallas | Texas | 75230 | — |
| GSK Investigational Site | Dallas | Texas | 75246 | — |
| GSK Investigational Site | Dallas | Texas | 75251 | — |
| GSK Investigational Site | El Paso | Texas | 79925 | — |
| GSK Investigational Site | Houston | Texas | 77024 | — |
| GSK Investigational Site | Houston | Texas | 77030 | — |
| GSK Investigational Site | Houston | Texas | 77058 | — |
| GSK Investigational Site | Houston | Texas | 77074 | — |
| GSK Investigational Site | Katy | Texas | 77450 | — |
| GSK Investigational Site | Lake Jackson | Texas | 77566 | — |
| GSK Investigational Site | Midland | Texas | 79707 | — |
| GSK Investigational Site | North Richland Hills | Texas | 76180 | — |
| GSK Investigational Site | San Antonio | Texas | 78215 | — |
| GSK Investigational Site | San Antonio | Texas | 78218 | — |
| GSK Investigational Site | Schertz | Texas | 78154 | — |
| GSK Investigational Site | Sugar Land | Texas | 77478 | — |
| GSK Investigational Site | Temple | Texas | 76508 | — |
| GSK Investigational Site | Bountiful | Utah | 84010 | — |
| GSK Investigational Site | Salt Lake City | Utah | 84102 | — |
| GSK Investigational Site | Salt Lake City | Utah | 84124 | — |
| GSK Investigational Site | South Burlington | Vermont | 05403 | — |
| GSK Investigational Site | Burke | Virginia | 22015 | — |
| GSK Investigational Site | Hampton | Virginia | 23666 | — |
| GSK Investigational Site | Manassas | Virginia | 20110 | — |
| GSK Investigational Site | Richmond | Virginia | 23294 | — |
| GSK Investigational Site | Spokane | Washington | 99216 | — |
| GSK Investigational Site | Tacoma | Washington | 98405 | — |
| GSK Investigational Site | Lewisburg | West Virginia | 24901 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 67 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00976391, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 11, 2017 · Synced Oct 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00976391 live on ClinicalTrials.gov.